Int J Gynecol Pathol. 2021 Mar 1;40(Suppl 1):S75-S91. doi: 10.1097/PGP.0000000000000751.
The incidence of endocervical adenocarcinoma, the second most common cervical cancer in the world, has been on the rise. While most cervical cancers are squamous cell carcinomas and associated with high-risk oncogenic human papillomavirus (HPV), approximately 15% of endocervical adenocarcinomas, which now represent about one quarter of all cervical cancers, are HPV-independent. In this review, we will focus on the shortcomings of historical histologic classification systems of female genital tract tumors as they pertain to endocervical adenocarcinomas, and we will highlight the advantages of the new International Endocervical Adenocarcinoma Criteria and Classification system, which forms the basis for the WHO 2020 classification. We will cover the various histologic types, subtypes, and variants of endocervical adenocarcinoma with regard to morphology, immunophenotype, molecular genetics, HPV status and differential diagnosis, and we will provide International Society of Gynecological Pathologists recommendations for diagnosing these tumors.
宫颈腺癌是世界上第二常见的宫颈癌,其发病率一直在上升。大多数宫颈癌为鳞状细胞癌,与高危致癌型人乳头瘤病毒(HPV)相关,而约 15%的宫颈腺癌与 HPV 无关,目前约占所有宫颈癌的四分之一。在这篇综述中,我们将重点讨论女性生殖道肿瘤的历史组织学分类系统在宫颈腺癌中的不足之处,并强调新的国际宫颈内膜腺癌标准和分类系统的优势,该系统是 2020 年世界卫生组织分类的基础。我们将讨论宫颈腺癌的各种组织学类型、亚型和变体,包括形态学、免疫表型、分子遗传学、HPV 状态和鉴别诊断,并提供国际妇科病理学会诊断这些肿瘤的建议。